Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

KN-62 inhibits MAPK/c-Myc activation and proliferation in human keratinocytes

Oct. 2, 2002

Phase I/II interim analysis of Targretin in chronic severe hand dermatitis

Oct. 1, 2002

Genmab's HuMax-CD4 enters phase IIb trial in psoriasis

Sep. 23, 2002

Primary efficacy endpoints reached in phase III Raptiva study

Sep. 19, 2002

Amevive application to be reviewed within six months

Sep. 19, 2002

Novel IL-8 antagonists and their use in psoriasis, arthritis, etc.

Sep. 18, 2002

BMOV enters phase II for treatment of severe burns in children

Sep. 17, 2002

Novel agents for stimulating melanocyte proliferation covered by BTG patent

Sep. 13, 2002

FDA requests additional phase III trial of Cellegesic

Sep. 12, 2002

SkyePharma and Meditech announce Solarase marketing agreement

Sep. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...